✦ LIBER ✦

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

✍ Scribed by P. P. Tak; R. M. Thurlings; C. Rossier; I. Nestorov; A. Dimic; V. Mircetic; M. Rischmueller; E. Nasonov; E. Shmidt; P. Emery; A. Munafo

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 209 KB
Volume: 58
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced B lymphocyte and immunoglobulin

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating trial

✍ Maria Dall'Era; Eliza Chakravarty; Daniel Wallace; Mark Genovese; Michael Weisma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

Golimumab in patients with active rheuma

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

Erratum: Golimumab in patients with acti

Erratum: Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial

✍ M. C. Genovese; N. Kinnman; G. de La Bourdonnaye; C. Pena Rossi; P. P. Tak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National